Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03275480

Institut Paoli Calmettes Myelodysplastic Syndromes Database

Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Myelodysplastic Syndromes Bone Marrow Diseases Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with a diagnosis of Myelodysplastic Syndromes

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Survival of patients with myelodysplastic syndrome(MDS)

    Time frame: 10 years

    Overall survival of all patients with MDS who are taken in charge in Institut Paoli Calmettes Cancer Center

Secondary outcomes

  1. Collection of patients characteristics

    Time frame: 10 years

    Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies

Study contacts

Contact information is provided by the study sponsor or research team.

Dominique Genre, MD

CONTACT

[email protected]

+33491223778

Lilian Laborde

CONTACT

[email protected]

+33491223778

Sponsors and collaborators

Lead sponsor

Institut Paoli-Calmettes

Other

Registry information

Important dates

Study start
2016
Primary completion
2030
Study completion
2030
First posted
Sep 7, 2017
Registry last updated
May 14, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.